Fundraising period opens for the C2C4C Latin America ride

The C2C4C Latin American ride will see over 55 employees from eight countries, including Argentina, Brazil, Chile, Colombia, Mexico, Peru, Puerto Rico, and the United States, cycling nearly 1,200 kilometres between Pucón and Puerto Varas, Chile. Each participant will cover approximately 360 kilometres over three days.

The event continues Bristol Myers Squibb’s efforts to support cancer research and patient care in the region as an esteemed partner of UICC. Since the expansion of the C2C4C initiative to Latin America in 2022, more than USD 250,000 have been donated to charitable organisations in the region. This year, Bristol Myers Squibb will contribute up to USD 50,000 to UICC to match funds raised by participants.

The C2C4C initiative began in the United States 11 years ago and has since expanded to Europe, where it is known as the Country 2 Country 4 Cancer, as well as Japan and now Latin America. To date, the programme has raised over USD 16 million for cancer research globally. Fundraising for C2C4C 2024 in Europe opened on 3 June and the event takes place from 6 to 24 September.

Many participants are motivated by personal connections to cancer, whether through their own experiences or those of loved ones. The aim is to support progress in cancer research and improve patient outcomes.

Donations can be made at www.uicc.org/c2c4cla, with options to support individual riders, teams, or the event as a whole. Funds raised will directly benefit cancer organisations in Latin America.

For updates, follow the ride on social media using the hashtag #C2C4C.